FDA Accepts Investigational New Drug Application for ARI-2243 and a First in Man Clinical Trial Set to Begin During the First Half of 2008
BOSTON, March 11 /PRNewswire/ -- arisaph
Pharmaceuticals, Inc., a
privately held drug disco...e, thereby contributing to
improvements in safety. arisaph
expects to initiate a first-in-man clinical
trial ... Kiritsy, President and Chief Executive
Officer of arisaph
Pharmaceuticals. "With ARI-2243, we are making pro...
Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4
Inhibitor, ARI-2243, at the ADA
...Ki of 27
BOSTON, June 25, 2007 /PRNewswire/ -- arisaph
Inc., a privately held drug disco...ferentiated
efficacy profile in diabetic patients. arisaph
completing IND enabling studies and e...cts to initiate
first-in-man testing in 2008.
designed ARI-2243 as a once a day, orally active, ...
Industry News Feeds : Press Room : Thomson Reuters
2006 SEP 8 - -- Arisaph
Pharmaceuticals, Inc. ... To trigger the second closing, Arisaph
successfully achieved its key development ...
Summary of KOS PHARMACEUTICALS INC - Yahoo! Finance
which later changed its name to Arisaph
Pharmaceuticals, Inc. (" Arisaph
"), through the purchase of shares of a new series of convertible ...
Arisaph Pharmaceuticals, Inc. Announces at the ADA</b> that Its Potent ...
BOSTON, June 8 /PRNewswire/ -- Arisaph
Pharmaceuticals, Inc. ... Arisaph
filed an IND for ARI-2243 during the first quarter of 2008 and has ...
Hung-Sen Lai Arisaph Pharmaceuticals Email @arisaph.com
Lead411's profile of Arisaph
Pharmaceuticals's Dir Medicinal Chemistry, Hung-Sen ... Lead411 subscription email addresses ( @arisaph
.com ) of the executives ...
Article: Arisaph Picked.(News)(Brief Article) - Chain Drug Review
Register today for a free trial, credit card req'd. Find Chain Drug Review articles plus many other academic journal articles, magazine articles & newspaper archives.
Arisaph Pharmaceuticals, Inc. :: Arisaph Pharmaceuticals Announces at ...Arisaph
Pharmaceuticals, Inc., a privately held drug discovery biopharmaceutical company, announced today at the 68th session of the American Diabetes Association ...